LAAO-1120 - Sequence # 4110 and 4115 | HAS-BLED Drugs - Antiplatelet & NSAIDS-1120 - Sequence # 4110 and 4115

1120 - Sequence # 4110 and 4115 | HAS-BLED Drugs - Antiplatelet & NSAIDS

Video Transcription

Video Summary

The video discusses the LAO Registry's monthly case scenario for November 2020, specifically focusing on two sequences: 4110 (HazBled Drugs Antiplatelet) and 4115 (HazBled Drugs NSAIDs). The case scenario involves Mr. Jackson, who has a medical history of longstanding persistent AFib, CHF, ischemic stroke, and uncontrolled hypertension, and takes medications including metoprolol, amiodarone, warfarin, and aspirin (162 milligrams). The question posed is how to code the aspirin in terms of the HazBled risk score. The answer is that it should be coded under Sequence 4110, Antiplatelet. The video provides further instructions on coding per the selection definition and differentiating between antiplatelet and NSAID medications. The HazBled risk score for Mr. Jackson includes hypertension, stroke, and antiplatelet use. The coding instructions will be updated in the Data Dictionary during the next upgrade.

Keywords

LAO Registry

monthly case scenario

HazBled risk score

antiplatelet

NSAID medications